potassium dichromate has been researched along with Lung Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Asha, P; Dai, J; Divya, SP; Hitron, JA; Kim, D; Pratheeshkumar, P; Roy, RV; Shi, X; Son, YO; Wang, L; Wang, Y; Zhang, Z | 1 |
Cheng, L; de Boer, J; Dixon, K; Sonntag, DM | 1 |
2 other study(ies) available for potassium dichromate and Lung Neoplasms
Article | Year |
---|---|
Luteolin inhibits Cr(VI)-induced malignant cell transformation of human lung epithelial cells by targeting ROS mediated multiple cell signaling pathways.
Topics: Angiogenic Proteins; Animals; Anticarcinogenic Agents; Apoptosis Regulatory Proteins; Bronchi; Cell Line; Cell Survival; Cell Transformation, Neoplastic; Chromium; Cytoprotection; Dose-Response Relationship, Drug; Epithelial Cells; Free Radical Scavengers; Humans; Inflammation Mediators; Lung Neoplasms; Luteolin; Mice, Nude; Oxidative Stress; Potassium Dichromate; Reactive Oxygen Species; Signal Transduction; Transfection; Xenograft Model Antitumor Assays | 2014 |
Chromium(VI)-induced mutagenesis in the lungs of big blue transgenic mice.
Topics: Animals; Antimetabolites; Buthionine Sulfoximine; Carcinogens; DNA; Dose-Response Relationship, Drug; Female; Glutathione; Instillation, Drug; Kidney; Liver; Lung; Lung Neoplasms; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutagenesis; Mutagens; Mutation; Potassium Dichromate; Trachea | 2000 |